Â¥
5.77
May 24
Business Description
Guangdong Hybribio Biotech Co Ltd
ISIN : CNE100002N51
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.19 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | -0.96 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.42 | |||||
Beneish M-Score | -1.15 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -3.8 | |||||
3-Year EBITDA Growth Rate | -22.4 | |||||
3-Year EPS without NRI Growth Rate | -29.7 | |||||
3-Year Book Growth Rate | 27.6 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 14.42 | |||||
9-Day RSI | 26.89 | |||||
14-Day RSI | 32.81 | |||||
6-1 Month Momentum % | -38.69 | |||||
12-1 Month Momentum % | -36.17 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.11 | |||||
Quick Ratio | 7.85 | |||||
Cash Ratio | 2.51 | |||||
Days Inventory | 98.33 | |||||
Days Sales Outstanding | 801.01 | |||||
Days Payable | 182.3 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.12 | |||||
Dividend Payout Ratio | 3.5 | |||||
3-Year Dividend Growth Rate | 70.2 | |||||
Forward Dividend Yield % | 1.12 | |||||
5-Year Yield-on-Cost % | 30.08 | |||||
3-Year Average Share Buyback Ratio | 0.7 | |||||
Shareholder Yield % | 6.99 |
Profitability Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.85 | |||||
Operating Margin % | -5.51 | |||||
Net Margin % | 6.17 | |||||
FCF Margin % | -9.3 | |||||
ROE % | 1.25 | |||||
ROA % | 1.01 | |||||
ROIC % | -0.13 | |||||
ROC (Joel Greenblatt) % | -1.77 | |||||
ROCE % | -1.06 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 44.05 | |||||
PE Ratio without NRI | 57.7 | |||||
Shiller PE Ratio | 9.62 | |||||
PEG Ratio | 1.76 | |||||
PS Ratio | 4.02 | |||||
PB Ratio | 0.77 | |||||
Price-to-Tangible-Book | 0.82 | |||||
Price-to-Operating-Cash-Flow | 17.7 | |||||
EV-to-EBIT | -51.55 | |||||
EV-to-EBITDA | -51.55 | |||||
EV-to-Revenue | 2.93 | |||||
EV-to-FCF | -33.79 | |||||
Price-to-Projected-FCF | 0.92 | |||||
Price-to-DCF (Earnings Based) | 1.84 | |||||
Price-to-Graham-Number | 1.45 | |||||
Price-to-Net-Current-Asset-Value | 1.64 | |||||
Price-to-Net-Cash | 17.48 | |||||
Earnings Yield (Greenblatt) % | -1.94 | |||||
FCF Yield % | -2.46 | |||||
Forward Rate of Return (Yacktman) % | 22.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Guangdong Hybribio Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 985.443 | ||
EPS (TTM) (Â¥) | 0.131 | ||
Beta | 0.68 | ||
Volatility % | 35.19 | ||
14-Day RSI | 32.81 | ||
14-Day ATR (Â¥) | 0.208475 | ||
20-Day SMA (Â¥) | 6.2215 | ||
12-1 Month Momentum % | -36.17 | ||
52-Week Range (Â¥) | 5.65 - 11.19 | ||
Shares Outstanding (Mil) | 646.5 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Guangdong Hybribio Biotech Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Guangdong Hybribio Biotech Co Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
Guangdong Hybribio Biotech Co Ltd Frequently Asked Questions
What is Guangdong Hybribio Biotech Co Ltd(SZSE:300639)'s stock price today?
When is next earnings date of Guangdong Hybribio Biotech Co Ltd(SZSE:300639)?
Does Guangdong Hybribio Biotech Co Ltd(SZSE:300639) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |